Last reviewed · How we verify
Topical Prednisolone Acetate Ophthalmic Drops
Topical Prednisolone Acetate Ophthalmic Drops is a Small molecule drug developed by William Wiley, MD. It is currently FDA-approved. Also known as: Prednisolone Acetate.
At a glance
| Generic name | Topical Prednisolone Acetate Ophthalmic Drops |
|---|---|
| Also known as | Prednisolone Acetate |
| Sponsor | William Wiley, MD |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Loteprednol Etabonate Versus Prednisolone Acetate for Anterior Chamber Granulomas (PHASE4)
- Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal Crosslinking (PHASE1, PHASE2)
- Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery (PHASE4)
- Dextenza in the Post-op Management of Vitreoretinal Surgeries (PHASE4)
- DEXTENZA in Pediatric Patients Following Retinal Surgery or Laser Treatment Under Anesthesia (EARLY_PHASE1)
- In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery (PHASE4)
- Dropless Pars Plana Vitrectomy Study (PHASE4)
- Clinical Outcomes of Cyclosporine Eye Drops in Management of Herpetic Keratitis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Topical Prednisolone Acetate Ophthalmic Drops CI brief — competitive landscape report
- Topical Prednisolone Acetate Ophthalmic Drops updates RSS · CI watch RSS
- William Wiley, MD portfolio CI
Frequently asked questions about Topical Prednisolone Acetate Ophthalmic Drops
What is Topical Prednisolone Acetate Ophthalmic Drops?
Topical Prednisolone Acetate Ophthalmic Drops is a Small molecule drug developed by William Wiley, MD.
Who makes Topical Prednisolone Acetate Ophthalmic Drops?
Topical Prednisolone Acetate Ophthalmic Drops is developed and marketed by William Wiley, MD (see full William Wiley, MD pipeline at /company/william-wiley-md).
Is Topical Prednisolone Acetate Ophthalmic Drops also known as anything else?
Topical Prednisolone Acetate Ophthalmic Drops is also known as Prednisolone Acetate.
What development phase is Topical Prednisolone Acetate Ophthalmic Drops in?
Topical Prednisolone Acetate Ophthalmic Drops is FDA-approved (marketed).
Related
- Manufacturer: William Wiley, MD — full pipeline
- Also known as: Prednisolone Acetate
- Compare: Topical Prednisolone Acetate Ophthalmic Drops vs similar drugs
- Pricing: Topical Prednisolone Acetate Ophthalmic Drops cost, discount & access